Free Trial

Virios Therapeutics Q2 2024 Earnings Report

Virios Therapeutics logo
$5.64 -0.34 (-5.69%)
As of 03/28/2025

Virios Therapeutics EPS Results

Actual EPS
-$0.05
Consensus EPS
-$0.07
Beat/Miss
Beat by +$0.02
One Year Ago EPS
-$0.08

Virios Therapeutics Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Virios Therapeutics Announcement Details

Quarter
Q2 2024
Time
Before Market Opens

Conference Call Resources

Remove Ads

Virios Therapeutics Earnings Headlines

Dogwood Therapeutics Inc (DWTX)
Dogwood prices 578,950 shares at $8.26 in registered direct offering
Crypto Genius: 12,000% in 12 months? [Here’s how]
We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.
Dogwood announces conversion of existing $19.5M in debt to equity
DWTX Stock trading resumes
Dogwood Therapeutics, Inc. (DWTX)
See More Virios Therapeutics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Virios Therapeutics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Virios Therapeutics and other key companies, straight to your email.

About Virios Therapeutics

Virios Therapeutics (NASDAQ:VIRI), a development-stage biotechnology company, focuses on developing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It also develops IMC-2, a combination of valacyclovir and celecoxib for the treatment of managing the fatigue, sleep, attention, pain, autonomic function, and anxiety associated with long COVID. The company was formerly known as Innovative Med Concepts, LLC and changed its name to Virios Therapeutics, Inc. in July 2020. The company was founded in 2012 and is headquartered in Alpharetta, Georgia.

View Virios Therapeutics Profile

More Earnings Resources from MarketBeat